WARING FEDERAL STRATEGIES for AUTM
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 8845 -- Making Appropriations for the Departments of Commerce and Justice, Science, and related Agencies for the Fiscal Year ending September 30,2027, and for other purposes (funding for NSF's tech transfer programs) H.R. 6500 -- Continuing Appropriations and Extensions Act, 2027
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL WARING | — |
Copyright/Patent/Trademark CPT
S. 708 and H.R. 1534 -- RESTORE Patent Rights Act of 2025 -- issues related to injunctions for patent infringement S. 1546 and H.R. 3152 -- Patent Eligibility Restoration Act -- related to clarifications of Section 101 of patent law S. 1553 and H.R. 3160 -- PREVAIL Act (Promoting and Respecting Economically Vital American Innovation Leadership Act -- related to reforms of the Patent Trials and Appeals Board at the US Patent and Trademark Office Teleconference with OIRA and USPTO re: Revision to Rules of Practice before the Patent Trial and Appeals Board Extension of PTO's fee-sharing authority which expired in September 2026 Restrictions in federal research grants that could lead to payments to government
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL WARING | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.